Please note: In October and November 2010, the MHRA moved from its Market Towers address to a new location on Buckingham Palace Road. Please go to the contact us section of the website for updated contact details.
In this issue
Drug safety advice
- Antiepileptics: suicidal thoughts and behaviour
- Recombinant human erythropoietins: new recommendations for treatment of anaemia in cancer
Yellow Card scheme update
- Serious versus severe reactions
Hot topic
- Thalidomide and lenalidomide for multiple myeloma
Stop Press
- Moxifloxacin: restricted use
- Caffeine for apnoea of prematurity: check dose regimen before use
- Accusol 35 solutions: precipitate formation during haemofiltration
- Intrathecal drug pumps: disrupted drug delivery
- Metronidazole for Clostridium-difficile-associated diarrhoea: use oral formulation
Other information from the MHRA
- Patient Information Leaflet of the month: AmBisome
- Unlicensed medicines
- Advertising complaints
- Public consultation: supply and administration of medicines by the armed forces
Drug Safety Update: Volume 2, Issue 1 August 2008 
